Impact of perioperative anticoagulation management on free flap survival in reconstructive surgery: a retrospective analysis.

IF 2.3 3区 医学 Q2 ANESTHESIOLOGY
Saeed Torabi, Remco Overbeek, Fabian Dusse, Sandra E Stoll, Carolin Schroeder, Max Zinser, Matthias Zirk
{"title":"Impact of perioperative anticoagulation management on free flap survival in reconstructive surgery: a retrospective analysis.","authors":"Saeed Torabi, Remco Overbeek, Fabian Dusse, Sandra E Stoll, Carolin Schroeder, Max Zinser, Matthias Zirk","doi":"10.1186/s12871-025-02975-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Despite advancements in surgical techniques and perioperative care for free flap reconstructive surgery, concerns persist regarding the risk of free flap failure, with thrombosis and bleeding being the most common complications that can lead to flap loss. While perioperative anticoagulation management is crucial for optimizing outcomes in free flap reconstructive surgery, standardized protocols remain lacking. This study aims to investigate the role of anticoagulation and perioperative practices in free flap reconstructive surgery and their impact on surgical outcomes.</p><p><strong>Methods: </strong>This retrospective, single-center study included all adult patients undergoing free flap surgery from 2009 to 2020. Patients were retrospectively divided based on intraoperative (UFH or no UFH) and postoperative anticoagulation management (UFH only, Aspirin and UFH, Aspirin only). The relationship between anticoagulation protocols, PTT values, and flap survival was assessed.</p><p><strong>Results: </strong>A total of 489 free flap surgeries were included. Most flaps were taken from the upper extremity (49.5%), primarily for tumor-related reconstructions (85.7%). Flap loss occurred in 14.5% of cases, with a median time to flap loss of 3 days post-surgery. Intraoperative UFH (20 IU/kg) was administered to 63.6% of patients and significantly predicted flap survival (OR = 0.45, 95% CI [0.24, 0.82]). PTT values on day 1 post-surgery were significantly related to flap survival (P = 0.03), with each unit increase reducing the relative probability of flap loss by 5.2%. There was no significant difference in flap survival between patients treated with heparin alone and those treated with both heparin and aspirin. The small sample size in the aspirin-only group limited the statistical relevance of this subgroup.</p><p><strong>Conclusion: </strong>Our findings highlight the importance of intraoperative UFH and PTT-guided postoperative management in improving free flap survival. Standardized anticoagulation protocols are essential for enhancing outcomes in free flap reconstructive surgery.</p>","PeriodicalId":9190,"journal":{"name":"BMC Anesthesiology","volume":"25 1","pages":"106"},"PeriodicalIF":2.3000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11863428/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Anesthesiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12871-025-02975-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Despite advancements in surgical techniques and perioperative care for free flap reconstructive surgery, concerns persist regarding the risk of free flap failure, with thrombosis and bleeding being the most common complications that can lead to flap loss. While perioperative anticoagulation management is crucial for optimizing outcomes in free flap reconstructive surgery, standardized protocols remain lacking. This study aims to investigate the role of anticoagulation and perioperative practices in free flap reconstructive surgery and their impact on surgical outcomes.

Methods: This retrospective, single-center study included all adult patients undergoing free flap surgery from 2009 to 2020. Patients were retrospectively divided based on intraoperative (UFH or no UFH) and postoperative anticoagulation management (UFH only, Aspirin and UFH, Aspirin only). The relationship between anticoagulation protocols, PTT values, and flap survival was assessed.

Results: A total of 489 free flap surgeries were included. Most flaps were taken from the upper extremity (49.5%), primarily for tumor-related reconstructions (85.7%). Flap loss occurred in 14.5% of cases, with a median time to flap loss of 3 days post-surgery. Intraoperative UFH (20 IU/kg) was administered to 63.6% of patients and significantly predicted flap survival (OR = 0.45, 95% CI [0.24, 0.82]). PTT values on day 1 post-surgery were significantly related to flap survival (P = 0.03), with each unit increase reducing the relative probability of flap loss by 5.2%. There was no significant difference in flap survival between patients treated with heparin alone and those treated with both heparin and aspirin. The small sample size in the aspirin-only group limited the statistical relevance of this subgroup.

Conclusion: Our findings highlight the importance of intraoperative UFH and PTT-guided postoperative management in improving free flap survival. Standardized anticoagulation protocols are essential for enhancing outcomes in free flap reconstructive surgery.

围手术期抗凝处理对游离皮瓣重建术后存活的影响:回顾性分析。
背景:尽管游离皮瓣重建手术的手术技术和围手术期护理有所进步,但人们仍然担心游离皮瓣失败的风险,血栓和出血是导致皮瓣丢失的最常见并发症。虽然围手术期抗凝管理是优化游离皮瓣重建手术结果的关键,但标准化的方案仍然缺乏。本研究旨在探讨抗凝和围手术期措施在游离皮瓣重建手术中的作用及其对手术结果的影响。方法:本研究为回顾性单中心研究,纳入2009年至2020年接受游离皮瓣手术的所有成年患者。根据术中(UFH或无UFH)和术后抗凝治疗(仅UFH、阿司匹林和仅UFH、阿司匹林)对患者进行回顾性分组。评估抗凝方案、PTT值与皮瓣存活之间的关系。结果:共纳入游离皮瓣手术489例。大部分皮瓣取自上肢(49.5%),主要用于肿瘤相关重建(85.7%)。14.5%的病例发生皮瓣丢失,术后中位皮瓣丢失时间为3天。63.6%的患者术中给予UFH (20 IU/kg),可显著预测皮瓣存活(OR = 0.45, 95% CI[0.24, 0.82])。术后第1天PTT值与皮瓣存活显著相关(P = 0.03),每增加一个单位,皮瓣丢失的相对概率降低5.2%。单用肝素治疗与联合用肝素和阿司匹林治疗的皮瓣存活率无显著差异。仅阿司匹林组的小样本量限制了该亚组的统计相关性。结论:我们的研究结果强调了术中UFH和ptt指导下的术后管理对提高游离皮瓣存活率的重要性。标准化的抗凝治疗方案对提高游离皮瓣重建手术的效果至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Anesthesiology
BMC Anesthesiology ANESTHESIOLOGY-
CiteScore
3.50
自引率
4.50%
发文量
349
审稿时长
>12 weeks
期刊介绍: BMC Anesthesiology is an open access, peer-reviewed journal that considers articles on all aspects of anesthesiology, critical care, perioperative care and pain management, including clinical and experimental research into anesthetic mechanisms, administration and efficacy, technology and monitoring, and associated economic issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信